Print ISSN:-2394-6369

Online ISSN:-2394-6377


Current Issue

Year 2020

Volume: 7 , Issue: 2

Article Access statistics

Viewed: 18

Emailed: 0

PDF Downloaded: 7

International Journal of Clinical Biochemistry and Research

Prevalence of hypoparathyroidism, growth retardation in patients of Beta-thalassemia major

Full Text PDF Share on Facebook Share on Twitter

Research Article

Author Details : Naresh Manne, Sandeep Kumar Yadav, Bharath Kumar Gupta*, Saurabh Singhal, Archana Dubey

Volume : 7, Issue : 2, Year : 2020

Article Page : 158-163

Suggest article by email


Background: Beta-Thalassemia is a genetic disorder which is associated with a lot of complications. Frequent blood transfusions result in increased iron deposition in various tissues leading to dysfunction of many vital organs. Endocrine disorders constitute a major part of such complications increasing the morbidity of thalassemia manifold in the affected patients. Early diagnosis of hypoparathyroidism (HPT) could prevent other severe disorders such as Tetany, seizures, osteopenia, and osteoporosis. Growth retardation can occur as complication of thalassemia as early as the 1st or 2nd year of life but these abnormalities more prominent after the 6 – 8 years of life.

Aim & Objectives: The aim of this study was carried out to determine; 1. The prevalence of (HPT) and Growth retardation in patients with beta and to correlate them with serum , calcium, phosphorus and alkaline levels; 2. The relationships of growth failure with certain variable including age, serum , mean hemoglobin level and gender of the patients.

Materials and Methods: This is a descriptive research study which was conducted on 200 subjects (100 cases and 100 controls) in the age group of 10-25 years who had visited the OPD/IPD of Subharti Medical College & affiliated Hospitals, . The cases included were with confirmed diagnosis of beta major, with regular blood transfusions and serum levels >2000 /ml irrespective of therapy.

Results: Out of 100 patients, was diagnosed in 18% patients, Growth retardation/ Short stature 93% and Weight loss was found in 93% patients. The mean age at diagnosis was 12.6 years (range 11-16 years), mean serum calcium was 7.53 mg/ (range7.58-9.04 mg/), mean serum was 5831.0 /ml (range 2000-8,064 /) and mean serum phosphate was 5.63 mg/ (range 4.50-7.73 mg/). Serum parathyroid hormone (PTH) levels were low in most of the patients. Short stature was observed in most of the patients, while it was found normal in control subjects.

Significant (HPT) observed along with growth retardation in beta patients (p < 0>

Keywords: Hypoparathyroidsm, Growth retardation, b - Thalassemia, Parathormone.

Doi : 10.18231/j.ijcbr.2020.034

How to cite : Manne N , Yadav S K, Gupta B K, Singhal S , Dubey A, Prevalence of hypoparathyroidism, growth retardation in patients of Beta-thalassemia major. Int J Clin Biochem Res 2020;7(2):158-163

Copyright © 2020 by author(s) and Int J Clin Biochem Res. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (